nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CYP2D6—breast cancer	0.0885	0.301	CbGaD
Olanzapine—FMO3—Tamoxifen—breast cancer	0.0853	0.168	CbGbCtD
Olanzapine—CYP3A4—breast cancer	0.0759	0.258	CbGaD
Olanzapine—ALB—breast cancer	0.0662	0.225	CbGaD
Olanzapine—ABCB1—breast cancer	0.0632	0.215	CbGaD
Olanzapine—HTR6—Raloxifene—breast cancer	0.0456	0.0897	CbGbCtD
Olanzapine—HTR2B—Raloxifene—breast cancer	0.0408	0.0801	CbGbCtD
Olanzapine—CYP1A2—Anastrozole—breast cancer	0.0191	0.0375	CbGbCtD
Olanzapine—CYP1A2—Toremifene—breast cancer	0.0175	0.0343	CbGbCtD
Olanzapine—CYP2C9—Anastrozole—breast cancer	0.0172	0.0338	CbGbCtD
Olanzapine—ABCB1—Toremifene—breast cancer	0.0153	0.03	CbGbCtD
Olanzapine—CYP2C19—Lapatinib—breast cancer	0.0138	0.0271	CbGbCtD
Olanzapine—CYP3A4—Exemestane—breast cancer	0.0132	0.0259	CbGbCtD
Olanzapine—CYP2C9—Idarubicin—breast cancer	0.013	0.0256	CbGbCtD
Olanzapine—CYP2D6—Idarubicin—breast cancer	0.0119	0.0234	CbGbCtD
Olanzapine—CYP3A4—Letrozole—breast cancer	0.0112	0.0221	CbGbCtD
Olanzapine—ABCB1—Lapatinib—breast cancer	0.0111	0.0219	CbGbCtD
Olanzapine—CYP3A4—Anastrozole—breast cancer	0.01	0.0197	CbGbCtD
Olanzapine—CYP3A4—Toremifene—breast cancer	0.00915	0.018	CbGbCtD
Olanzapine—CYP3A4—Fulvestrant—breast cancer	0.00851	0.0167	CbGbCtD
Olanzapine—ALB—Irinotecan—breast cancer	0.00819	0.0161	CbGbCtD
Olanzapine—ALB—Fluorouracil—breast cancer	0.00786	0.0154	CbGbCtD
Olanzapine—CYP3A4—Thiotepa—breast cancer	0.00758	0.0149	CbGbCtD
Olanzapine—CYP2C9—Capecitabine—breast cancer	0.00715	0.014	CbGbCtD
Olanzapine—CYP3A4—Ixabepilone—breast cancer	0.00694	0.0136	CbGbCtD
Olanzapine—CYP2C19—Tamoxifen—breast cancer	0.00691	0.0136	CbGbCtD
Olanzapine—CYP3A4—Lapatinib—breast cancer	0.00668	0.0131	CbGbCtD
Olanzapine—CYP1A2—Tamoxifen—breast cancer	0.00638	0.0125	CbGbCtD
Olanzapine—ABCB1—Vinorelbine—breast cancer	0.00618	0.0121	CbGbCtD
Olanzapine—CYP2D6—Vinorelbine—breast cancer	0.00582	0.0114	CbGbCtD
Olanzapine—CYP2C9—Tamoxifen—breast cancer	0.00575	0.0113	CbGbCtD
Olanzapine—ABCB1—Tamoxifen—breast cancer	0.00558	0.011	CbGbCtD
Olanzapine—ABCB1—Mitoxantrone—breast cancer	0.00544	0.0107	CbGbCtD
Olanzapine—CYP2D6—Tamoxifen—breast cancer	0.00526	0.0103	CbGbCtD
Olanzapine—CYP3A4—Raloxifene—breast cancer	0.00506	0.00994	CbGbCtD
Olanzapine—ABCB1—Gemcitabine—breast cancer	0.00481	0.00944	CbGbCtD
Olanzapine—CYP1A2—Fluorouracil—breast cancer	0.0047	0.00924	CbGbCtD
Olanzapine—CYP2C9—Paclitaxel—breast cancer	0.00447	0.00879	CbGbCtD
Olanzapine—ABCB1—Paclitaxel—breast cancer	0.00434	0.00853	CbGbCtD
Olanzapine—ALB—Methotrexate—breast cancer	0.00433	0.00852	CbGbCtD
Olanzapine—ABCB1—Irinotecan—breast cancer	0.00428	0.00842	CbGbCtD
Olanzapine—CYP2C9—Fluorouracil—breast cancer	0.00424	0.00832	CbGbCtD
Olanzapine—ABCB1—Vinblastine—breast cancer	0.00381	0.00748	CbGbCtD
Olanzapine—CYP3A4—Vinorelbine—breast cancer	0.0037	0.00728	CbGbCtD
Olanzapine—CYP2D6—Vinblastine—breast cancer	0.00359	0.00705	CbGbCtD
Olanzapine—CHRM3—muscle of abdomen—breast cancer	0.00341	0.074	CbGeAlD
Olanzapine—CYP3A4—Tamoxifen—breast cancer	0.00334	0.00657	CbGbCtD
Olanzapine—CYP3A4—Mitoxantrone—breast cancer	0.00326	0.00641	CbGbCtD
Olanzapine—ABCB1—Docetaxel—breast cancer	0.00314	0.00617	CbGbCtD
Olanzapine—CYP3A4—Paclitaxel—breast cancer	0.0026	0.00511	CbGbCtD
Olanzapine—CYP3A4—Irinotecan—breast cancer	0.00257	0.00504	CbGbCtD
Olanzapine—ABCB1—Doxorubicin—breast cancer	0.00234	0.0046	CbGbCtD
Olanzapine—CYP3A4—Vinblastine—breast cancer	0.00228	0.00448	CbGbCtD
Olanzapine—ABCB1—Methotrexate—breast cancer	0.00227	0.00445	CbGbCtD
Olanzapine—CYP2D6—Doxorubicin—breast cancer	0.00221	0.00433	CbGbCtD
Olanzapine—CYP3A4—Docetaxel—breast cancer	0.00188	0.0037	CbGbCtD
Olanzapine—CYP3A4—Doxorubicin—breast cancer	0.0014	0.00276	CbGbCtD
Olanzapine—HRH4—bone marrow—breast cancer	0.00127	0.0276	CbGeAlD
Olanzapine—H1F0—mammary gland—breast cancer	0.00112	0.0244	CbGeAlD
Olanzapine—H1F0—nipple—breast cancer	0.00093	0.0202	CbGeAlD
Olanzapine—ALB—mammary gland—breast cancer	0.000841	0.0183	CbGeAlD
Olanzapine—H1F0—embryo—breast cancer	0.000767	0.0167	CbGeAlD
Olanzapine—CHRM5—epithelium—breast cancer	0.000726	0.0158	CbGeAlD
Olanzapine—HRH2—skin of body—breast cancer	0.000723	0.0157	CbGeAlD
Olanzapine—HTR1E—female gonad—breast cancer	0.000716	0.0155	CbGeAlD
Olanzapine—FMO3—pituitary gland—breast cancer	0.000693	0.015	CbGeAlD
Olanzapine—CHRM5—skin of body—breast cancer	0.00069	0.015	CbGeAlD
Olanzapine—FMO3—adipose tissue—breast cancer	0.00069	0.015	CbGeAlD
Olanzapine—FMO3—adrenal gland—breast cancer	0.000619	0.0134	CbGeAlD
Olanzapine—DRD5—female reproductive system—breast cancer	0.000601	0.013	CbGeAlD
Olanzapine—H1F0—skin of body—breast cancer	0.000595	0.0129	CbGeAlD
Olanzapine—H1F0—endometrium—breast cancer	0.000561	0.0122	CbGeAlD
Olanzapine—HRH2—adrenal gland—breast cancer	0.000551	0.012	CbGeAlD
Olanzapine—DRD5—female gonad—breast cancer	0.000547	0.0119	CbGeAlD
Olanzapine—FMO3—endocrine gland—breast cancer	0.000537	0.0116	CbGeAlD
Olanzapine—ADRA2C—nipple—breast cancer	0.000527	0.0114	CbGeAlD
Olanzapine—CYP2C9—mammary gland—breast cancer	0.000525	0.0114	CbGeAlD
Olanzapine—H1F0—uterus—breast cancer	0.000517	0.0112	CbGeAlD
Olanzapine—DRD5—endocrine gland—breast cancer	0.000509	0.011	CbGeAlD
Olanzapine—H1F0—pituitary gland—breast cancer	0.000508	0.011	CbGeAlD
Olanzapine—H1F0—adipose tissue—breast cancer	0.000506	0.011	CbGeAlD
Olanzapine—ORM1—endometrium—breast cancer	0.000479	0.0104	CbGeAlD
Olanzapine—HRH2—endocrine gland—breast cancer	0.000478	0.0104	CbGeAlD
Olanzapine—H1F0—female reproductive system—breast cancer	0.000465	0.0101	CbGeAlD
Olanzapine—CYP1A2—nipple—breast cancer	0.000458	0.00993	CbGeAlD
Olanzapine—H1F0—adrenal gland—breast cancer	0.000454	0.00985	CbGeAlD
Olanzapine—H1F0—bone marrow—breast cancer	0.000439	0.00953	CbGeAlD
Olanzapine—HTR2B—skin of body—breast cancer	0.000429	0.00931	CbGeAlD
Olanzapine—HRH1—nipple—breast cancer	0.000428	0.0093	CbGeAlD
Olanzapine—H1F0—female gonad—breast cancer	0.000423	0.00919	CbGeAlD
Olanzapine—ADRA2A—nipple—breast cancer	0.000421	0.00913	CbGeAlD
Olanzapine—HTR2B—endometrium—breast cancer	0.000405	0.00878	CbGeAlD
Olanzapine—ORM1—female reproductive system—breast cancer	0.000397	0.00862	CbGeAlD
Olanzapine—H1F0—endocrine gland—breast cancer	0.000394	0.00854	CbGeAlD
Olanzapine—HTR7—epithelium—breast cancer	0.000386	0.00839	CbGeAlD
Olanzapine—ORM1—bone marrow—breast cancer	0.000375	0.00813	CbGeAlD
Olanzapine—HTR2B—uterus—breast cancer	0.000373	0.00809	CbGeAlD
Olanzapine—ADRA1A—epithelium—breast cancer	0.000373	0.00809	CbGeAlD
Olanzapine—HTR1B—female reproductive system—breast cancer	0.000372	0.00808	CbGeAlD
Olanzapine—FMO3—lymph node—breast cancer	0.000371	0.00805	CbGeAlD
Olanzapine—HTR2B—adipose tissue—breast cancer	0.000365	0.00791	CbGeAlD
Olanzapine—HTR1D—female reproductive system—breast cancer	0.00036	0.00782	CbGeAlD
Olanzapine—HTR2C—female reproductive system—breast cancer	0.000357	0.00774	CbGeAlD
Olanzapine—ALB—adrenal gland—breast cancer	0.00034	0.00737	CbGeAlD
Olanzapine—CHRM1—female reproductive system—breast cancer	0.000337	0.00731	CbGeAlD
Olanzapine—ORM1—endocrine gland—breast cancer	0.000336	0.00729	CbGeAlD
Olanzapine—HTR2B—female reproductive system—breast cancer	0.000335	0.00727	CbGeAlD
Olanzapine—HRH2—lymph node—breast cancer	0.00033	0.00717	CbGeAlD
Olanzapine—CHRM3—adipose tissue—breast cancer	0.000328	0.00712	CbGeAlD
Olanzapine—HTR2B—adrenal gland—breast cancer	0.000327	0.0071	CbGeAlD
Olanzapine—ADRA2C—endometrium—breast cancer	0.000318	0.00691	CbGeAlD
Olanzapine—HTR1B—endocrine gland—breast cancer	0.000315	0.00684	CbGeAlD
Olanzapine—CHRM2—endocrine gland—breast cancer	0.000313	0.0068	CbGeAlD
Olanzapine—CHRM3—female reproductive system—breast cancer	0.000301	0.00654	CbGeAlD
Olanzapine—ADRA1A—adipose tissue—breast cancer	0.000301	0.00654	CbGeAlD
Olanzapine—DRD2—pituitary gland—breast cancer	0.000296	0.00643	CbGeAlD
Olanzapine—HTR2A—embryo—breast cancer	0.000295	0.00641	CbGeAlD
Olanzapine—ADRA2C—uterus—breast cancer	0.000293	0.00637	CbGeAlD
Olanzapine—HTR1A—adrenal gland—breast cancer	0.000293	0.00636	CbGeAlD
Olanzapine—HRH1—epithelium—breast cancer	0.000288	0.00626	CbGeAlD
Olanzapine—ADRA2C—pituitary gland—breast cancer	0.000288	0.00625	CbGeAlD
Olanzapine—HTR7—female reproductive system—breast cancer	0.000287	0.00623	CbGeAlD
Olanzapine—ADRA2C—adipose tissue—breast cancer	0.000287	0.00623	CbGeAlD
Olanzapine—CHRM1—endocrine gland—breast cancer	0.000285	0.00619	CbGeAlD
Olanzapine—HTR7—adrenal gland—breast cancer	0.00028	0.00608	CbGeAlD
Olanzapine—CHRM3—female gonad—breast cancer	0.000274	0.00596	CbGeAlD
Olanzapine—H1F0—lymph node—breast cancer	0.000272	0.00591	CbGeAlD
Olanzapine—ADRA1A—adrenal gland—breast cancer	0.00027	0.00586	CbGeAlD
Olanzapine—HRH1—endometrium—breast cancer	0.000259	0.00561	CbGeAlD
Olanzapine—ADRA2C—adrenal gland—breast cancer	0.000257	0.00559	CbGeAlD
Olanzapine—CHRM3—endocrine gland—breast cancer	0.000255	0.00554	CbGeAlD
Olanzapine—HTR1A—endocrine gland—breast cancer	0.000254	0.00552	CbGeAlD
Olanzapine—ADRA2A—endometrium—breast cancer	0.000254	0.00552	CbGeAlD
Olanzapine—HTR7—endocrine gland—breast cancer	0.000243	0.00527	CbGeAlD
Olanzapine—HTR2A—epithelium—breast cancer	0.000241	0.00523	CbGeAlD
Olanzapine—ADRA2C—female gonad—breast cancer	0.00024	0.00521	CbGeAlD
Olanzapine—CYP2C19—endocrine gland—breast cancer	0.000237	0.00515	CbGeAlD
Olanzapine—ADRA1A—endocrine gland—breast cancer	0.000234	0.00508	CbGeAlD
Olanzapine—ADRA2A—uterus—breast cancer	0.000234	0.00508	CbGeAlD
Olanzapine—HRH1—adipose tissue—breast cancer	0.000233	0.00506	CbGeAlD
Olanzapine—ORM1—lymph node—breast cancer	0.000232	0.00504	CbGeAlD
Olanzapine—ADRA2A—pituitary gland—breast cancer	0.00023	0.00499	CbGeAlD
Olanzapine—DRD2—endocrine gland—breast cancer	0.00023	0.00498	CbGeAlD
Olanzapine—ADRA2A—adipose tissue—breast cancer	0.000229	0.00497	CbGeAlD
Olanzapine—CYP2C9—female reproductive system—breast cancer	0.000217	0.00472	CbGeAlD
Olanzapine—HRH1—female reproductive system—breast cancer	0.000214	0.00465	CbGeAlD
Olanzapine—ADRA2A—female reproductive system—breast cancer	0.00021	0.00457	CbGeAlD
Olanzapine—HRH1—adrenal gland—breast cancer	0.000209	0.00454	CbGeAlD
Olanzapine—ADRA2A—adrenal gland—breast cancer	0.000205	0.00446	CbGeAlD
Olanzapine—ALB—lymph node—breast cancer	0.000204	0.00442	CbGeAlD
Olanzapine—HTR2B—lymph node—breast cancer	0.000196	0.00426	CbGeAlD
Olanzapine—HTR2A—pituitary gland—breast cancer	0.000195	0.00424	CbGeAlD
Olanzapine—HRH1—female gonad—breast cancer	0.000195	0.00423	CbGeAlD
Olanzapine—CYP1A2—endocrine gland—breast cancer	0.000194	0.0042	CbGeAlD
Olanzapine—ABCB1—embryo—breast cancer	0.000193	0.0042	CbGeAlD
Olanzapine—ADRA2A—female gonad—breast cancer	0.000191	0.00416	CbGeAlD
Olanzapine—CYP2C9—endocrine gland—breast cancer	0.000184	0.00399	CbGeAlD
Olanzapine—HRH1—endocrine gland—breast cancer	0.000181	0.00394	CbGeAlD
Olanzapine—HTR2A—female reproductive system—breast cancer	0.000179	0.00388	CbGeAlD
Olanzapine—ADRA2A—endocrine gland—breast cancer	0.000178	0.00387	CbGeAlD
Olanzapine—HTR2A—adrenal gland—breast cancer	0.000175	0.00379	CbGeAlD
Olanzapine—CYP3A4—female reproductive system—breast cancer	0.000166	0.0036	CbGeAlD
Olanzapine—CYP2D6—female reproductive system—breast cancer	0.000163	0.00354	CbGeAlD
Olanzapine—ABCB1—epithelium—breast cancer	0.000158	0.00343	CbGeAlD
Olanzapine—ADRA2C—lymph node—breast cancer	0.000154	0.00335	CbGeAlD
Olanzapine—HTR2A—endocrine gland—breast cancer	0.000151	0.00329	CbGeAlD
Olanzapine—CYP2D6—female gonad—breast cancer	0.000148	0.00322	CbGeAlD
Olanzapine—ABCB1—endometrium—breast cancer	0.000142	0.00307	CbGeAlD
Olanzapine—CYP3A4—endocrine gland—breast cancer	0.00014	0.00304	CbGeAlD
Olanzapine—Clozapine—CYP1B1—breast cancer	0.00014	0.228	CrCbGaD
Olanzapine—CYP2D6—endocrine gland—breast cancer	0.000138	0.00299	CbGeAlD
Olanzapine—ABCB1—uterus—breast cancer	0.00013	0.00283	CbGeAlD
Olanzapine—ABCB1—pituitary gland—breast cancer	0.000128	0.00278	CbGeAlD
Olanzapine—ABCB1—adipose tissue—breast cancer	0.000128	0.00277	CbGeAlD
Olanzapine—HRH1—lymph node—breast cancer	0.000125	0.00272	CbGeAlD
Olanzapine—ADRA2A—lymph node—breast cancer	0.000123	0.00267	CbGeAlD
Olanzapine—ABCB1—female reproductive system—breast cancer	0.000117	0.00255	CbGeAlD
Olanzapine—ABCB1—adrenal gland—breast cancer	0.000114	0.00248	CbGeAlD
Olanzapine—ABCB1—bone marrow—breast cancer	0.000111	0.0024	CbGeAlD
Olanzapine—ABCB1—female gonad—breast cancer	0.000107	0.00232	CbGeAlD
Olanzapine—ABCB1—endocrine gland—breast cancer	9.92e-05	0.00215	CbGeAlD
Olanzapine—Amoxapine—CYP2D6—breast cancer	8.59e-05	0.14	CrCbGaD
Olanzapine—Clozapine—CYP1A1—breast cancer	7.57e-05	0.123	CrCbGaD
Olanzapine—ABCB1—lymph node—breast cancer	6.86e-05	0.00149	CbGeAlD
Olanzapine—Quetiapine—CYP2D6—breast cancer	6.55e-05	0.106	CrCbGaD
Olanzapine—Clozapine—CYP2D6—breast cancer	5.63e-05	0.0916	CrCbGaD
Olanzapine—Quetiapine—CYP3A4—breast cancer	5.62e-05	0.0913	CrCbGaD
Olanzapine—Clozapine—CYP3A4—breast cancer	4.83e-05	0.0786	CrCbGaD
Olanzapine—Quetiapine—ABCB1—breast cancer	4.68e-05	0.076	CrCbGaD
Olanzapine—Clozapine—ABCB1—breast cancer	4.02e-05	0.0654	CrCbGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.05e-06	6.95e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—breast cancer	1.05e-06	6.94e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK8—breast cancer	1.05e-06	6.93e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.04e-06	6.93e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—breast cancer	1.04e-06	6.92e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.04e-06	6.92e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.04e-06	6.91e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—breast cancer	1.04e-06	6.91e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.04e-06	6.9e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.04e-06	6.89e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TYMS—breast cancer	1.04e-06	6.89e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.04e-06	6.87e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.03e-06	6.86e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—breast cancer	1.03e-06	6.85e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PIK3CA—breast cancer	1.03e-06	6.82e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NOS3—breast cancer	1.03e-06	6.81e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NCOR1—breast cancer	1.03e-06	6.81e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.03e-06	6.81e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTM1—breast cancer	1.03e-06	6.81e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.03e-06	6.8e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SRC—breast cancer	1.03e-06	6.8e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.02e-06	6.8e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.02e-06	6.8e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—breast cancer	1.02e-06	6.79e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.02e-06	6.79e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.02e-06	6.76e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.02e-06	6.76e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—breast cancer	1.02e-06	6.74e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.02e-06	6.74e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.02e-06	6.74e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HRAS—breast cancer	1.01e-06	6.73e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—breast cancer	1.01e-06	6.72e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—breast cancer	1.01e-06	6.71e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.01e-06	6.7e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SRC—breast cancer	1.01e-06	6.7e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SRC—breast cancer	1.01e-06	6.68e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SRC—breast cancer	1e-06	6.66e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HRAS—breast cancer	1e-06	6.66e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—breast cancer	1e-06	6.65e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—breast cancer	1e-06	6.65e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KRAS—breast cancer	1e-06	6.65e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SRC—breast cancer	1e-06	6.64e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—breast cancer	1e-06	6.63e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—breast cancer	9.99e-07	6.63e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—breast cancer	9.97e-07	6.61e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—breast cancer	9.96e-07	6.61e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	9.94e-07	6.6e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	9.92e-07	6.58e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SRC—breast cancer	9.91e-07	6.57e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—breast cancer	9.91e-07	6.57e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTEN—breast cancer	9.9e-07	6.57e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—breast cancer	9.89e-07	6.56e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SRC—breast cancer	9.88e-07	6.56e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CG—breast cancer	9.87e-07	6.55e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—breast cancer	9.86e-07	6.54e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—breast cancer	9.83e-07	6.52e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GPX1—breast cancer	9.82e-07	6.52e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—breast cancer	9.81e-07	6.51e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—breast cancer	9.81e-07	6.51e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—breast cancer	9.79e-07	6.5e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—breast cancer	9.78e-07	6.49e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—breast cancer	9.75e-07	6.47e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—breast cancer	9.74e-07	6.47e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—breast cancer	9.73e-07	6.46e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—breast cancer	9.73e-07	6.46e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CYP1A1—breast cancer	9.72e-07	6.45e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—breast cancer	9.71e-07	6.44e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CB—breast cancer	9.71e-07	6.44e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—breast cancer	9.7e-07	6.44e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	9.68e-07	6.43e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—breast cancer	9.68e-07	6.42e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NOS3—breast cancer	9.67e-07	6.42e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KRAS—breast cancer	9.67e-07	6.42e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	9.66e-07	6.41e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—breast cancer	9.65e-07	6.4e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—breast cancer	9.65e-07	6.4e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ERCC2—breast cancer	9.64e-07	6.4e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	9.62e-07	6.38e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KRAS—breast cancer	9.62e-07	6.38e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—breast cancer	9.62e-07	6.38e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—breast cancer	9.6e-07	6.37e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NOS3—breast cancer	9.59e-07	6.36e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HRAS—breast cancer	9.56e-07	6.34e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—breast cancer	9.55e-07	6.34e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—breast cancer	9.53e-07	6.32e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—breast cancer	9.53e-07	6.32e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CB—breast cancer	9.47e-07	6.29e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK3—breast cancer	9.45e-07	6.27e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HRAS—breast cancer	9.43e-07	6.26e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—breast cancer	9.39e-07	6.23e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—breast cancer	9.38e-07	6.22e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KRAS—breast cancer	9.36e-07	6.21e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTEN—breast cancer	9.34e-07	6.2e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK3—breast cancer	9.3e-07	6.17e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK3—breast cancer	9.28e-07	6.16e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—breast cancer	9.25e-07	6.14e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK3—breast cancer	9.25e-07	6.14e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK3—breast cancer	9.22e-07	6.12e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KRAS—breast cancer	9.21e-07	6.11e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	9.2e-07	6.11e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—breast cancer	9.19e-07	6.1e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SRC—breast cancer	9.18e-07	6.09e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—breast cancer	9.17e-07	6.08e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—breast cancer	9.15e-07	6.07e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK3—breast cancer	9.13e-07	6.06e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	9.1e-07	6.04e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PIK3CA—breast cancer	9.1e-07	6.04e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MTHFR—breast cancer	9.07e-07	6.02e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—breast cancer	9.04e-07	6e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—breast cancer	9.03e-07	5.99e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—breast cancer	9.02e-07	5.99e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—breast cancer	9.02e-07	5.98e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—breast cancer	9e-07	5.97e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—breast cancer	8.99e-07	5.97e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—breast cancer	8.99e-07	5.96e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—breast cancer	8.97e-07	5.95e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—breast cancer	8.97e-07	5.95e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—breast cancer	8.95e-07	5.94e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—breast cancer	8.94e-07	5.93e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	8.94e-07	5.93e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CB—breast cancer	8.93e-07	5.92e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—breast cancer	8.9e-07	5.91e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	8.89e-07	5.9e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—breast cancer	8.88e-07	5.89e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—breast cancer	8.86e-07	5.88e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—breast cancer	8.86e-07	5.88e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—breast cancer	8.85e-07	5.87e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—breast cancer	8.85e-07	5.87e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CB—breast cancer	8.85e-07	5.87e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—breast cancer	8.85e-07	5.87e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—breast cancer	8.84e-07	5.87e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	8.84e-07	5.86e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	8.83e-07	5.86e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—breast cancer	8.83e-07	5.86e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—breast cancer	8.8e-07	5.84e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—breast cancer	8.77e-07	5.82e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—breast cancer	8.77e-07	5.82e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—breast cancer	8.68e-07	5.76e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CD—breast cancer	8.68e-07	5.76e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—breast cancer	8.66e-07	5.75e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	8.6e-07	5.7e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—breast cancer	8.6e-07	5.7e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—breast cancer	8.57e-07	5.68e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—breast cancer	8.55e-07	5.67e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HRAS—breast cancer	8.52e-07	5.65e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KRAS—breast cancer	8.49e-07	5.63e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	8.46e-07	5.61e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	8.46e-07	5.61e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—breast cancer	8.44e-07	5.6e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—breast cancer	8.4e-07	5.57e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTEN—breast cancer	8.39e-07	5.56e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAV1—breast cancer	8.36e-07	5.55e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KRAS—breast cancer	8.35e-07	5.54e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3CA—breast cancer	8.35e-07	5.54e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KRAS—breast cancer	8.34e-07	5.53e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—breast cancer	8.33e-07	5.53e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—breast cancer	8.32e-07	5.52e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KRAS—breast cancer	8.31e-07	5.51e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KRAS—breast cancer	8.28e-07	5.5e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—breast cancer	8.23e-07	5.46e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HRAS—breast cancer	8.22e-07	5.45e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	8.21e-07	5.44e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KRAS—breast cancer	8.2e-07	5.44e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NOS3—breast cancer	8.19e-07	5.44e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTEN—breast cancer	8.19e-07	5.43e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—breast cancer	8.19e-07	5.43e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KRAS—breast cancer	8.18e-07	5.43e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HRAS—breast cancer	8.18e-07	5.43e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—breast cancer	8.15e-07	5.41e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—breast cancer	8.05e-07	5.34e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HRAS—breast cancer	7.95e-07	5.28e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—breast cancer	7.87e-07	5.22e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HRAS—breast cancer	7.83e-07	5.19e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—breast cancer	7.83e-07	5.19e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CA—breast cancer	7.8e-07	5.18e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTEN—breast cancer	7.71e-07	5.12e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	7.68e-07	5.09e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CA—breast cancer	7.66e-07	5.08e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTEN—breast cancer	7.65e-07	5.07e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	7.63e-07	5.07e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CG—breast cancer	7.62e-07	5.05e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—breast cancer	7.61e-07	5.05e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	7.61e-07	5.05e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KRAS—breast cancer	7.6e-07	5.04e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CB—breast cancer	7.56e-07	5.02e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—breast cancer	7.55e-07	5.01e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	7.54e-07	5e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—breast cancer	7.52e-07	4.99e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	7.52e-07	4.99e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—breast cancer	7.49e-07	4.97e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—breast cancer	7.49e-07	4.97e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—breast cancer	7.44e-07	4.93e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—breast cancer	7.43e-07	4.93e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—breast cancer	7.41e-07	4.92e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—breast cancer	7.39e-07	4.9e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—breast cancer	7.36e-07	4.89e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—breast cancer	7.29e-07	4.84e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—breast cancer	7.27e-07	4.82e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—breast cancer	7.26e-07	4.82e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—breast cancer	7.22e-07	4.79e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HRAS—breast cancer	7.22e-07	4.79e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HRAS—breast cancer	7.1e-07	4.71e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HRAS—breast cancer	7.09e-07	4.7e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HRAS—breast cancer	7.06e-07	4.69e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HRAS—breast cancer	7.04e-07	4.67e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—breast cancer	7.02e-07	4.66e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	6.98e-07	4.63e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HRAS—breast cancer	6.97e-07	4.63e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HRAS—breast cancer	6.95e-07	4.61e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—breast cancer	6.91e-07	4.59e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—breast cancer	6.91e-07	4.58e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—breast cancer	6.82e-07	4.53e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—breast cancer	6.8e-07	4.51e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—breast cancer	6.78e-07	4.5e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—breast cancer	6.76e-07	4.49e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—breast cancer	6.76e-07	4.48e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—breast cancer	6.74e-07	4.47e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CD—breast cancer	6.7e-07	4.44e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—breast cancer	6.67e-07	4.43e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—breast cancer	6.66e-07	4.42e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—breast cancer	6.61e-07	4.39e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CA—breast cancer	6.59e-07	4.37e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTEN—breast cancer	6.54e-07	4.34e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HRAS—breast cancer	6.46e-07	4.29e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—breast cancer	6.37e-07	4.23e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NOS3—breast cancer	6.32e-07	4.2e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—breast cancer	6.27e-07	4.16e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—breast cancer	6.26e-07	4.15e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—breast cancer	6.24e-07	4.14e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—breast cancer	6.22e-07	4.13e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—breast cancer	6.18e-07	4.1e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—breast cancer	6.16e-07	4.09e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—breast cancer	6.14e-07	4.07e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CA—breast cancer	5.92e-07	3.93e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CB—breast cancer	5.84e-07	3.87e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—breast cancer	5.78e-07	3.84e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CA—breast cancer	5.78e-07	3.83e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—breast cancer	5.7e-07	3.79e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CA—breast cancer	5.44e-07	3.61e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CA—breast cancer	5.4e-07	3.58e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—breast cancer	5.38e-07	3.57e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTEN—breast cancer	5.04e-07	3.35e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—breast cancer	4.83e-07	3.21e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—breast cancer	4.72e-07	3.13e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CA—breast cancer	4.61e-07	3.06e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—breast cancer	4.45e-07	2.95e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—breast cancer	4.41e-07	2.92e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—breast cancer	3.77e-07	2.5e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CA—breast cancer	3.56e-07	2.36e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—breast cancer	2.91e-07	1.93e-06	CbGpPWpGaD
